Identification of a stable chymase inhibitor using a pharmacophore-Based database search (Q44239551)

1 December 2017

Identification of a stable chymase inhibitor using a pharmacophore-Based database search (English)

1 reference

1 December 2017

Yuuki Koide

1

1 reference

1 December 2017

Akira Tatsui

2

1 reference

1 December 2017

Takeshi Hasegawa

3

1 reference

1 December 2017

Akira Murakami

4

1 reference

1 December 2017

Shoji Satoh

5

1 reference

1 December 2017

Hideki Yamada

6

1 reference

1 December 2017

Shin-ichi Kazayama

7

1 reference

1 December 2017

Atsuo Takahashi

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

1 December 2017

1 reference

1 December 2017

13

1 reference

1 December 2017

1

1 reference

1 December 2017

25-29

1 reference

Characterization of chymase from human vascular tissues

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Angiotensin II generation by mast cell alpha- and beta-chymases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Angiotensin I Conversion by Human and Rat Chymotryptic Proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Inhibition of chymase reduces vascular proliferation in dog grafted veins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Induction of chymase that forms angiotensin II in the monkey atherosclerotic aorta.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Absence of association between a variant of the mast cell chymase gene and atopic dermatitis in an Italian population.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Non-peptidic inhibitors of human chymase. Synthesis, structure-activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic alpha-keto heterocycles as novel inhibitors of human chymase.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic difluoromethylene ketones as novel inhibitors of human chymase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Beneficial effects of cardiac chymase inhibition during the acute phase of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Oral administration of a specific chymase inhibitor, NK3201, inhibits vascular proliferation in grafted vein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

An orally active chymase inhibitor, BCEAB, suppresses heart chymase activity in the hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900853-3

7 January 2021

10.1016/S0960-894X(02)00853-3

Identifiers

DOI

1 reference

1 December 2017

1 reference